Medtronic Annualized CHF Sales Of $300 Mil. Driven By Physician Training
This article was originally published in The Gray Sheet
Executive Summary
Medtronic capitalized on its first-mover advantage with a cardiac resynchronization device for congestive heart failure by aggressively training physicians with its InSync biventricular pacer